Copyright
©The Author(s) 2024.
World J Clin Cases. Jul 26, 2024; 12(21): 4601-4608
Published online Jul 26, 2024. doi: 10.12998/wjcc.v12.i21.4601
Published online Jul 26, 2024. doi: 10.12998/wjcc.v12.i21.4601
Premedication | Post medication | Value of difference (post medication- premedication) | P value | |
Maximum diameter of myoma (n = 73, mm) | 22.79 ± 14.52 | 24.84 ± 16.22 | 2.04 | 0.002 |
Myoma volume (n = 73, mm) | 10.71 ± 21.15 | 15.66 ± 31.65 | 4.96 | 0.001 |
Uterine volume (n = 73, mm3) | 139.56 ± 89.68 | 142.38 ± 90.56 | 2.82 | 0.686 |
Maximum diameter of adenomyoma (n = 30, mm) | 44.7 ± 13.57 | 45.97 ± 16.38 | 1.27 | 0.471 |
Adenomyoma volume (n = 30, mm3) | 42.09 ± 33.27 | 47.15 ± 46.06 | 5.19 | 0.443 |
Maximum diameter of the cyst (n = 40, mm) | 33.48 ± 13 | 31.13 ± 11.47 | -2.35 | 0.134 |
Volume of the cyst (n = 40, mm3) | 18.18 ± 20.33 | 12.74 ± 12.06 | -5.45 | 0.022 |
Endometrial thickness (n = 73, mm) | 5.93 ± 3.27 | 4.48 ± 2.14 | -1.45 | < 0.001 |
- Citation: Zhang DY, Huang Y, Peng C, Zhou YF. Effect of dienogest treatment on uterine fibroid volume in patients with endometriosis or adenomyosis complicated by uterine fibroids. World J Clin Cases 2024; 12(21): 4601-4608
- URL: https://www.wjgnet.com/2307-8960/full/v12/i21/4601.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i21.4601